|
?:authorAffiliation
|
-
[\'Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20814, USA.\', \'Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.\', \'Ph.D. program in Immunology and Virology, University of Duisburg-Essen, Essen, Germany.\', \'Ph.D. program in Virology, Division of Medical Sciences, Harvard University, Boston, MA 02138, USA.\', \'Centers for Childhood Infections and Vaccines, Children\'s Healthcare of Atlanta and Emory University, Department of Pediatrics, Atlanta, GA, 30329, USA.\', \'Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA.\', \'Yerkes National Primate Research Center, Atlanta, GA 30329, USA.\', \'Sanofi Pasteur, Marcy l\'Etoile, France.\', \'Sanofi Pasteur, 38 Sidney Street, Cambridge, MA 02139, USA.\', \'Bioqual Inc., Rockville, MD 20850, USA.\', \'GSK, Wavre, Belgium.\', \'GSK, Rixensart, Belgium.\', \'Duke Human Vaccine Institute, Duke University, Durham, NC 27708, USA.\', \'Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20814, USA. rseder@mail.nih.gov.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}